Goar Kimovna Arutyunyan
Goar Kimovna Arutyunyan has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniy V. Merkulov
E.I. Chazov National Medical Research Center Of Cardiology
14 shared publications - Andrey S. Tereshchenko
Chazov National Medical Research Center of Cardiology
9 shared publications - Dmitry V. Pevzner
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation; M.F. Vladimirsky Moscow Regional Research and Clinical Institute
9 shared publications - Tatiana S. Sukhinina
Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
7 shared publications - Vsevolod M. Mironov
Chazov National Medical Research Center of Cardiology
6 shared publications - Irina N. Merkulova
Chazov National Medical Research Center of Cardiology
4 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 90-97
Assessment of fractional flow reserve and instantaneous wave-free ratio dynamics in patients with st-segment elevation myocardial infarction and its dependence on the presence of microvascular obstruction in the infarct zone
Objective. To analyze the dynamics of coronary physiology indices — fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) — in the infarct-related artery (IRA) and non-infarct-related artery (non-IRA) during the first 24 hours of ST-segment elevation myocardial infarction (STEMI) and in the early postinfarction period, and to assess their dependence on the presence of microvascular obstruction (MVO) in the infarct zone as determined by contrast-enhanced cardiac magnetic resonance imaging (MRI). Materials and methods. FFR and iFR were measured in the IRA and non-IRA after primary percutaneous coronary intervention (pPCI) on the IRA in patients with STEMI and at least one 50–85% stenosis in a non-IRA. Papaverine was used to induce hyperemia for FFR assessment. Cardiac MRI was performed on days 3–5 to evaluate the presence and extent of MVO in the infarct zone. Repeated coronary angiography with FFR and iFR measurement was performed at 30–45 days; based on the results, non-IRA stenting was performed when FFR ≤ 0.80 and/or iFR ≤ 0.89. To achieve the study objective, the dynamics of coronary physiology indices in the IRA and non-IRA were assessed in the overall cohort and in subgroups with and without MVO on MRI. Statistical analysis included the Wilcoxon signed-rank test, the Mann–Whitney U test, and Spearman's correlation. Results. Thirty-two patients were enrolled. MVO was detected in 13 patients (40.6%). No statistically significant changes in FFR or iFR between the index procedure and repeated assessment were found in either the IRA or the non-IRA (p=0.856 and 0.597 for FFR, p=0.092 and 0.511 for iFR, in the IRA and non-IRA, respectively). The presence of MVO with an extent of 2.47% [0.66%; 5.06%] was not associated with significant differences in FFR or iFR dynamics (p=0.488 (FFR), p=0.089 (iFR) in the IRA; p=0.460 (FFR) and 0.144 (iFR) in the non-IRA). MVO extent of 2.47% [0.66%; 5.06%] did not correlate with changes in FFR or iFR in either the IRA or the non-IRA (the most pronounced trend was observed for ΔiFR in the IRA: ρ=−0.529, p=0.063). Categorical classification stability was 92.0% for FFR and 86.0% for iFR. Conclusion. In hemodynamically stable patients with STEMI and intermediate nonIRA stenoses, FFR and iFR values in both the non-IRA and the IRA after pPCI remain stable during the first 24 hours of MI and in the early postinfarction period. Coronary physiology indices (FFR, iFR) can be used for decision-making regarding non-IRA PCI during the index procedure. In patients with STEMI with a median ejection fraction of 52.5% [49.75%; 58.25%] and MVO extent of 2.47% [0.66%; 5.06%], the presence of MVO did not distort the reproducibility of FFR and iFR measurements in the non-IRA and IRA after pPCI.
- 30 September 2026
- Published by Intermedservice Ltd in Eurasian heart journal
- No. 3,p. 90-97
Open AccessAssessment of fractional flow reserve and instantaneous wave-free ratio dynamics in patients with st-segment elevation myocardial infarction and its dependence on the presence of microvascular obstruction in the infarct zone
Objective. To analyze the dynamics of coronary physiology indices — fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) — in the infarct-related artery (IRA) and non-infarct-related artery (non-IRA) during the first 24 hours of ST-segment elevation myocardial infarction (STEMI) and in the early postinfarction period, and to assess their dependence on the presence of microvascular obstruction (MVO) in the infarct zone as determined by contrast-enhanced cardiac magnetic resonance imaging (MRI). Materials and methods. FFR and iFR were measured in the IRA and non-IRA after primary percutaneous coronary intervention (pPCI) on the IRA in patients with STEMI and at least one 50–85% stenosis in a non-IRA. Papaverine was used to induce hyperemia for FFR assessment. Cardiac MRI was performed on days 3–5 to evaluate the presence and extent of MVO in the infarct zone. Repeated coronary angiography with FFR and iFR measurement was performed at 30–45 days; based on the results, non-IRA stenting was performed when FFR ≤ 0.80 and/or iFR ≤ 0.89. To achieve the study objective, the dynamics of coronary physiology indices in the IRA and non-IRA were assessed in the overall cohort and in subgroups with and without MVO on MRI. Statistical analysis included the Wilcoxon signed-rank test, the Mann–Whitney U test, and Spearman's correlation. Results. Thirty-two patients were enrolled. MVO was detected in 13 patients (40.6%). No statistically significant changes in FFR or iFR between the index procedure and repeated assessment were found in either the IRA or the non-IRA (p=0.856 and 0.597 for FFR, p=0.092 and 0.511 for iFR, in the IRA and non-IRA, respectively). The presence of MVO with an extent of 2.47% [0.66%; 5.06%] was not associated with significant differences in FFR or iFR dynamics (p=0.488 (FFR), p=0.089 (iFR) in the IRA; p=0.460 (FFR) and 0.144 (iFR) in the non-IRA). MVO extent of 2.47% [0.66%; 5.06%] did not correlate with changes in FFR or iFR in either the IRA or the non-IRA (the most pronounced trend was observed for ΔiFR in the IRA: ρ=−0.529, p=0.063). Categorical classification stability was 92.0% for FFR and 86.0% for iFR. Conclusion. In hemodynamically stable patients with STEMI and intermediate nonIRA stenoses, FFR and iFR values in both the non-IRA and the IRA after pPCI remain stable during the first 24 hours of MI and in the early postinfarction period. Coronary physiology indices (FFR, iFR) can be used for decision-making regarding non-IRA PCI during the index procedure. In patients with STEMI with a median ejection fraction of 52.5% [49.75%; 58.25%] and MVO extent of 2.47% [0.66%; 5.06%], the presence of MVO did not distort the reproducibility of FFR and iFR measurements in the non-IRA and IRA after pPCI.
- Open Access
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 22-32
STAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP
Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.
- 4 September 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (4) , 22-32
Open AccessSTAGED MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY ARTERY DISEASE BASED ON CORONARY PHYSIOLOGY PARAMETERS IN NON-INFARCT-RELATED ARTERIES: ANALYSIS OF OUTCOMES ACCORDING TO MID-TERM FOLLOW-UP
Highlights The study demonstrates that in patients with uncomplicated STEMI and intermediate stenoses of non-infarct-related arteries, performing staged complete revascularization only with a hemodynamically significant fractional flow reserve (FFR) value ≤ 0.80 at 30–45 days after primary intervention is associated with no cases of cardiovascular death and recurrent myocardial infarction over a median follow-up of 21 months. The uniqueness of the approach lies in the selection of hemodynamically significant stenoses, which avoided excessive stenting in 40% of patients without worsening prognosis. Thus, the work makes an important contribution to the rationale for FFR-guided staged complete revascularization in STEMI patients with multivessel coronary artery disease. Aim. To evaluate the incidence of major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease after staged complete revascularization of non-infarct-related arteries (non-IRAs) guided by fractional flow reserve (FFR). Methods. This single-center prospective study included 52 patients with STEMI and intermediate non-IRA stenoses (50–85%). All patients underwent primary percutaneous coronary intervention of the infarct-related artery. At 30–45 days, FFR assessment in non-IRAs was performed; revascularization was performed when FFR ≤ 0.80. Median follow-up was 21 months. The primary endpoint was cardiovascular death and recurrent myocardial infarction. Results. Hemodynamically significant stenoses were identified in 31 patients (59.6%), who underwent stenting; 21 patients (40.4%) received only medical therapy. During the follow-up period, no cases of cardiovascular death or recurrent myocardial infarction were recorded (0%; 95% CI 0.0–5.6%). Repeat revascularization was performed in 4 patients (7.7%), and 2 cases of non-cardiovascular death (3.8%) were recorded. No cases of contrast-induced nephropathy, clinically significant bleeding, or stroke were observed. Conclusion. In patients with uncomplicated STEMI and intermediate non-IRA stenoses, an FFR-guided staged complete revascularization strategy performed at 30–45 days after primary intervention was associated with a low incidence of cardiovascular events; no cases of cardiovascular death or recurrent myocardial infarction were recorded in this cohort. This approach avoids excessive stenting but requires confirmation in larger studies.
- Open Access
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6496
Trends in intravascular diagnostics development in the Russian Federation: four-year data from the Russian registry on intravascular imaging and physiology methods
Aim. To analyze the results of the use and development trends of intravascular diagnostic methods based on four-year data from the Russian registry on the use of intravascular imaging and physiology methods. Material and methods . In 2024, data on 13125 examinations in 5408 patients were entered into the registry, and the registry includes information on 33154 procedures in 14311 patients. The database design and content continued to be refined, with several sections significantly revised. The most significant changes affected the sections on immediate and late surgical outcomes. To standardize the intravascular imaging evaluation during endovascular interventions, quantitative parameters were introduced, with semi-automated calculation of final coefficients and derivation of final conclusions. Results. Over 4 years, 30 departments from 18 Russian cities participated in the registry. The average number of examinations per patient increased from 1,96 in 2021 to 2,43 in 2024. There is a trend toward an increasing role for intravascular ultrasound, with a decline in the use of optical coherence tomography and, to a lesser extent, fractional flow reserve. The share of intravascular ultrasound increased from 37% to 66%, while optical coherence tomography decreased from 23% to 5%, and fractional flow reserve decreased from 40% to 29%. Approximately 20% of studies were performed for acute coronary syndrome (19% of which were for ST-segment elevation myocardial infarction), while 2% were performed for noncoronary pathology. The largest number of studies were performed at the initial and final stages of surgery, followed by primary diagnostic studies, intraoperative monitoring, and diagnostic studies during patient follow-up. Conclusion . The registry provides an objective means of analyzing intravascular diagnostic methods in Russia. Improving the registry and standardizing approaches to performing and evaluating data from intravascular techniques allows for an objective assessment of intervention results and contributes to their improvement. A number of clinics across the country routinely use intravascular diagnostic techniques, including for acute coronary syndrome and non-coronary pathology.
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6496
Open AccessTrends in intravascular diagnostics development in the Russian Federation: four-year data from the Russian registry on intravascular imaging and physiology methods
Aim. To analyze the results of the use and development trends of intravascular diagnostic methods based on four-year data from the Russian registry on the use of intravascular imaging and physiology methods. Material and methods . In 2024, data on 13125 examinations in 5408 patients were entered into the registry, and the registry includes information on 33154 procedures in 14311 patients. The database design and content continued to be refined, with several sections significantly revised. The most significant changes affected the sections on immediate and late surgical outcomes. To standardize the intravascular imaging evaluation during endovascular interventions, quantitative parameters were introduced, with semi-automated calculation of final coefficients and derivation of final conclusions. Results. Over 4 years, 30 departments from 18 Russian cities participated in the registry. The average number of examinations per patient increased from 1,96 in 2021 to 2,43 in 2024. There is a trend toward an increasing role for intravascular ultrasound, with a decline in the use of optical coherence tomography and, to a lesser extent, fractional flow reserve. The share of intravascular ultrasound increased from 37% to 66%, while optical coherence tomography decreased from 23% to 5%, and fractional flow reserve decreased from 40% to 29%. Approximately 20% of studies were performed for acute coronary syndrome (19% of which were for ST-segment elevation myocardial infarction), while 2% were performed for noncoronary pathology. The largest number of studies were performed at the initial and final stages of surgery, followed by primary diagnostic studies, intraoperative monitoring, and diagnostic studies during patient follow-up. Conclusion . The registry provides an objective means of analyzing intravascular diagnostic methods in Russia. Improving the registry and standardizing approaches to performing and evaluating data from intravascular techniques allows for an objective assessment of intervention results and contributes to their improvement. A number of clinics across the country routinely use intravascular diagnostic techniques, including for acute coronary syndrome and non-coronary pathology.
- 16 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (3)
Coronary physiology indicators for assessing the stenosis functional significance in non-infarct-related arteries in patients with ST-segment elevation myocardial infarction
Aim . To study the informative value of invasive coronary physiology indices (fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)) and to evaluate the safety of papaverine as a hyperemic agent to determine the hemodynamic significance of stenoses in non-infarction-related arteries (non-IRA) in patients with ST-segment elevation myocardial infarction (STEMI) during the index procedure after primary percutaneous coronary intervention (PPCI). Material and methods . This single-center prospective study included 32 patients over 18 years of age with STEMI and 50-85% stenosis in 38 non-IRA. After PPCI of the infarction-related artery, iFR, contrast-enhanced FFR, and (if there were no contraindications) FFR with papaverine were measured. Rehospitalization was performed 30-45 days later with follow-up coronary angiography and reassessment of physiological parameters. Statistical analysis included Spearman’s rank order coefficient (SRCC), intraclass correlation (ICC), Cohen’s kappa coefficient, Bland-Altman analysis, and McNemar’s test (α=0,05). Results . Analysis of 38 non-IRAs (36 FFR tests with papaverine) demonstrated high reproducibility as follows: iFR — ρ=0,94 (pConclusion . FFR with papaverine and iFR can be safely and informatively used to assess the hemodynamic significance of non-IRA stenoses in hemodynamically stable patients during the first 24 hours after STEMI. The high stability of these parameters during repeated measurements confirms their suitability for dynamic monitoring. Borderline values require careful interpretation and possible use of additional ischemia verification methods.
- 16 April 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (3)
Coronary physiology indicators for assessing the stenosis functional significance in non-infarct-related arteries in patients with ST-segment elevation myocardial infarction
Aim . To study the informative value of invasive coronary physiology indices (fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR)) and to evaluate the safety of papaverine as a hyperemic agent to determine the hemodynamic significance of stenoses in non-infarction-related arteries (non-IRA) in patients with ST-segment elevation myocardial infarction (STEMI) during the index procedure after primary percutaneous coronary intervention (PPCI). Material and methods . This single-center prospective study included 32 patients over 18 years of age with STEMI and 50-85% stenosis in 38 non-IRA. After PPCI of the infarction-related artery, iFR, contrast-enhanced FFR, and (if there were no contraindications) FFR with papaverine were measured. Rehospitalization was performed 30-45 days later with follow-up coronary angiography and reassessment of physiological parameters. Statistical analysis included Spearman’s rank order coefficient (SRCC), intraclass correlation (ICC), Cohen’s kappa coefficient, Bland-Altman analysis, and McNemar’s test (α=0,05). Results . Analysis of 38 non-IRAs (36 FFR tests with papaverine) demonstrated high reproducibility as follows: iFR — ρ=0,94 (pConclusion . FFR with papaverine and iFR can be safely and informatively used to assess the hemodynamic significance of non-IRA stenoses in hemodynamically stable patients during the first 24 hours after STEMI. The high stability of these parameters during repeated measurements confirms their suitability for dynamic monitoring. Borderline values require careful interpretation and possible use of additional ischemia verification methods.
- Open Access
- 10 March 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (3) , e269921
TAV-in-TAV-in-TAV after treated endocarditis: procedural strategy, imaging planning and 1-year outcome
Given the diverse technical challenges associated with transcatheter valve-in-transcatheter valve procedures, the treatment strategy for each clinical case must be tailored to the individual patient. We present the case of a man in his late 70s with a complex clinical history, including two prior transcatheter aortic valve implantation (TAVI) procedures and infective endocarditis, who later developed severe degeneration of the aortic prosthesis requiring a third transcatheter intervention. Initially treated with a Lotus valve in 2014, the patient underwent a TAV-in-TAV with an Evolut prosthesis in 2022, followed by endocarditis-related degeneration and severe restenosis. In 2024, a third prosthetic valve (Acurate neo2) was implanted using the TAV-in-TAV-in-TAV technique. With expanding indications for TAVI and increasing longevity among treated patients, complex multi-prosthesis interventions may become more frequent, highlighting the need for improved procedural planning, imaging strategies and long-term surveillance. At 1-year follow-up, the patient remains asymptomatic with preserved valve function. This case illustrates the feasibility of a third TAVI after treated prosthetic valve endocarditis, supported by CT-guided procedural planning and 1-year follow-up, which remains scarcely reported in the literature.
- 10 March 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (3) , e269921
Open AccessTAV-in-TAV-in-TAV after treated endocarditis: procedural strategy, imaging planning and 1-year outcome
Given the diverse technical challenges associated with transcatheter valve-in-transcatheter valve procedures, the treatment strategy for each clinical case must be tailored to the individual patient. We present the case of a man in his late 70s with a complex clinical history, including two prior transcatheter aortic valve implantation (TAVI) procedures and infective endocarditis, who later developed severe degeneration of the aortic prosthesis requiring a third transcatheter intervention. Initially treated with a Lotus valve in 2014, the patient underwent a TAV-in-TAV with an Evolut prosthesis in 2022, followed by endocarditis-related degeneration and severe restenosis. In 2024, a third prosthetic valve (Acurate neo2) was implanted using the TAV-in-TAV-in-TAV technique. With expanding indications for TAVI and increasing longevity among treated patients, complex multi-prosthesis interventions may become more frequent, highlighting the need for improved procedural planning, imaging strategies and long-term surveillance. At 1-year follow-up, the patient remains asymptomatic with preserved valve function. This case illustrates the feasibility of a third TAVI after treated prosthetic valve endocarditis, supported by CT-guided procedural planning and 1-year follow-up, which remains scarcely reported in the literature.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 145-154
Sensitivity and specificity of various physiological indices of coronary blood flow for functional assessment of coronary artery stenosis
Objective. To analyze sensitivity and specificity of non-hyperemic indices (Pd/Pa, diastolic blood flow reserve), contrast-induced hyperemia index (cFFR) compared with fractional flow reserve (FFR) in patients with coronary artery disease (CAD) and various lesions of coronary arteries. Material and methods. The study included 61 patients with chronic CAD, coronary artery stenosis >50% and diameter >2.5 mm as assessed by angiography. A total of 108 lesions were enrolled. Of these, FFR was assessed in 79, non-hyperemic indices were measured in 74, and contrast-induced hyperemia index was assessed in 37 cases. All indices were analyzed in comparison with FFR. The criterion for hemodynamic significance of stenosis was FFR≤0.80. Analysis of correlation, sensitivity and specificity of these parameters was performed. False-negative and false-positive results were assessed at cut-off DFR≤0.89. Results. cFFR significantly positively correlates with FFR (p<0.0001, r=0.803). Non-hyperemic indices positively moderately correlate with FFR (for Pd/Pa p<0.0001, r=0.61; for DFR p<0.0001, r=0.587). In cFFR with cut-off value ≤ 0.83, sensitivity was 84.6%, specificity — 100%. In Pd/Pa with cut-off value ≤0.91, sensitivity was 73.5%, specificity — 80%. For DFR≤0.89, the sensitivity was 83.7%; specificity 68%. DFR can depend on measurements in different coronary arteries. There were significant differences towards underestimation of non-hyperemic indices in LAD and overestimation in RCA and LCx (p<0.001). Conclusion. Contrast-induced hyperemia index (cFFR) may be an alternative to FFR with papaverine. Although predictive value of non-hyperemic Pd/Pa and DFR indices was acceptable, they depended on anatomical localization of lesion. This can require further research.
- 30 December 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (4) , 145-154
Sensitivity and specificity of various physiological indices of coronary blood flow for functional assessment of coronary artery stenosis
Objective. To analyze sensitivity and specificity of non-hyperemic indices (Pd/Pa, diastolic blood flow reserve), contrast-induced hyperemia index (cFFR) compared with fractional flow reserve (FFR) in patients with coronary artery disease (CAD) and various lesions of coronary arteries. Material and methods. The study included 61 patients with chronic CAD, coronary artery stenosis >50% and diameter >2.5 mm as assessed by angiography. A total of 108 lesions were enrolled. Of these, FFR was assessed in 79, non-hyperemic indices were measured in 74, and contrast-induced hyperemia index was assessed in 37 cases. All indices were analyzed in comparison with FFR. The criterion for hemodynamic significance of stenosis was FFR≤0.80. Analysis of correlation, sensitivity and specificity of these parameters was performed. False-negative and false-positive results were assessed at cut-off DFR≤0.89. Results. cFFR significantly positively correlates with FFR (p<0.0001, r=0.803). Non-hyperemic indices positively moderately correlate with FFR (for Pd/Pa p<0.0001, r=0.61; for DFR p<0.0001, r=0.587). In cFFR with cut-off value ≤ 0.83, sensitivity was 84.6%, specificity — 100%. In Pd/Pa with cut-off value ≤0.91, sensitivity was 73.5%, specificity — 80%. For DFR≤0.89, the sensitivity was 83.7%; specificity 68%. DFR can depend on measurements in different coronary arteries. There were significant differences towards underestimation of non-hyperemic indices in LAD and overestimation in RCA and LCx (p<0.001). Conclusion. Contrast-induced hyperemia index (cFFR) may be an alternative to FFR with papaverine. Although predictive value of non-hyperemic Pd/Pa and DFR indices was acceptable, they depended on anatomical localization of lesion. This can require further research.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Ultrasound catheter thrombolysis for the treatment of pulmonary embolism: the first experience in the Russian Federation
Treatment of pulmonary embolism (PE) is still an urgent problem worldwide due to complications of systemic thrombolytic therapy. This review examines ultrasound catheter thrombolysis using the EKOS system, indications, patient selection and current state of the issue. The device itself, appropriate manipulations and several clinical cases in the Russian Federation are described in detail. The authors described implantation technique and ultrasound thrombolysis.
- 18 September 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (3)
Ultrasound catheter thrombolysis for the treatment of pulmonary embolism: the first experience in the Russian Federation
Treatment of pulmonary embolism (PE) is still an urgent problem worldwide due to complications of systemic thrombolytic therapy. This review examines ultrasound catheter thrombolysis using the EKOS system, indications, patient selection and current state of the issue. The device itself, appropriate manipulations and several clinical cases in the Russian Federation are described in detail. The authors described implantation technique and ultrasound thrombolysis.
- 14 April 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (1)
Comparison of fluoroscopy and intracardiac echocardiography for control of endovascular closure of patent foramen ovale
Objective. To compare the results of endovascular closure of patent foramen ovale (PFO) under fluoroscopy and intracardiac echocardiography (ICE). Material and methods. The study included 212 patients who underwent endovascular closure of PFO between 2019 and 2023. The subjects were divided into two groups: fluoroscopy (FS) in 183 patients and ICE in 29 patients. Clinical status of patients was analyzed for 12 months. We estimated technical features of surgery, complications, efficacy of procedure and recurrent adverse events. Results. Surgery time in the ICE group was 40.00 [30.00; 60.00] min, and patients were not exposed to radiation. The occluder was placed in optimal position in all patients. In the FS group, surgery time was 60.00 [45.00; 75.00] min (p=0.0067), radiation time and dose — 612.00 [381.00; 952.50] sec and 9.30 [6.52; 15.12] mSv, respectively. The most serious complications in the FS group were supraventricular tachycardia in 9 (4.92%), mitral valve contact in 1 (0.55%), hemopericardium in 2 (1.09%), and TIA in 1 (0.55%) patient. The length of hospital-stay was 7.00 [4.00; 8.00] days. In the ICE group, we observed vein thrombosis in 1 (3.45%) and body temperature elevation >an 37.1°C in 2 (6.90%) cases. The length of hospital-stay was 5.00 [3.00; 6.00] days (p=0.0016). After 12 months, TIA and ischemic stroke occurred in 2 (0.58%) patients of the FS group, respectively. No vascular catastrophes were recorded in the ICE group. Conclusion. ICE-guided endovascular closure of PFO demonstrated better efficacy and safety.
- 14 April 2025
- Published by Media Sphere Publishing Group in Russian Cardiology Bulletin
- Vol. 20 (1)
Comparison of fluoroscopy and intracardiac echocardiography for control of endovascular closure of patent foramen ovale
Objective. To compare the results of endovascular closure of patent foramen ovale (PFO) under fluoroscopy and intracardiac echocardiography (ICE). Material and methods. The study included 212 patients who underwent endovascular closure of PFO between 2019 and 2023. The subjects were divided into two groups: fluoroscopy (FS) in 183 patients and ICE in 29 patients. Clinical status of patients was analyzed for 12 months. We estimated technical features of surgery, complications, efficacy of procedure and recurrent adverse events. Results. Surgery time in the ICE group was 40.00 [30.00; 60.00] min, and patients were not exposed to radiation. The occluder was placed in optimal position in all patients. In the FS group, surgery time was 60.00 [45.00; 75.00] min (p=0.0067), radiation time and dose — 612.00 [381.00; 952.50] sec and 9.30 [6.52; 15.12] mSv, respectively. The most serious complications in the FS group were supraventricular tachycardia in 9 (4.92%), mitral valve contact in 1 (0.55%), hemopericardium in 2 (1.09%), and TIA in 1 (0.55%) patient. The length of hospital-stay was 7.00 [4.00; 8.00] days. In the ICE group, we observed vein thrombosis in 1 (3.45%) and body temperature elevation >an 37.1°C in 2 (6.90%) cases. The length of hospital-stay was 5.00 [3.00; 6.00] days (p=0.0016). After 12 months, TIA and ischemic stroke occurred in 2 (0.58%) patients of the FS group, respectively. No vascular catastrophes were recorded in the ICE group. Conclusion. ICE-guided endovascular closure of PFO demonstrated better efficacy and safety.
- Open Access
- 26 June 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (2) , 43-49
Evaluation of functional significance of coronary arteries stenoses with estimation of fractional flow reserve based on computed tomography angiography data
Оценка функциональной значимости стенозов коронарных артерий с помощью определения фракционного резерва кровотока на основании данных компьютерной томографической ангиографии
- 26 June 2024
- Published by Intermedservice Ltd in Systemic Hypertension
- Vol. 21 (2) , 43-49
Open AccessEvaluation of functional significance of coronary arteries stenoses with estimation of fractional flow reserve based on computed tomography angiography data
Оценка функциональной значимости стенозов коронарных артерий с помощью определения фракционного резерва кровотока на основании данных компьютерной томографической ангиографии
- Open Access
- 24 June 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (12S) , 6009
Atrial fibrillation as a complication of endovascular patent foramen ovale closure: a clinical trial
One of the known potential complications associated with endovascular closure of the patent foramen ovale (PFO) is de novo atrial fibrillation (AF).Aim. To assess the risk factors and incidence of de novo AF in patients who underwent endovascular PFO closure.Material and methods. The data of 276 patients who underwent endovascular PFO closure for the period from 2020 to 2023 at the Chazov National Medical Research Center of Cardiology were analyzed. All patients underwent examinations in accordance with clinical guidelines. De novo AF in the postoperative period was assessed by Holter monitoring, while 1, 6 and 12 months after the intervention — by electrocardiographic recording. Based on univariate regression analysis, risk factors associated with de novo AF were identified.Results. De novo AF in the postoperative period was registered in 2 patients. One month after the intervention, AF episodes were diagnosed in 6 patients. After 6 months, AF detected earlier persisted in 3 patients,and there were 3 new cases. Twelve months after the intervention, AF was recorded in 2 patients. According to regression analysis, the following parameters were associated with de novo AF: age ≥52,0 years (hazard ratio (HR) 6,22; 95% confidence interval (CI): 1,51-25,56), body mass index ≥28,07 kg/m2 (HR 8,48; 95% CI: 1,72-41,73), CHARGE-AF score ≥0,56 (HR 4,59; 95% CI: 1,12-18,82), left atrial size ≥4,00 cm (HR 19,56; 95% CI: 2,10-181,88), LAVi ≥34 ml/m2 (HR 45,67; 95% CI: 5,46-381,83) according to echocardiography.Conclusion. Echocardiographic signs of left atrial and left ventricular dilation were significantly associated with a high risk of de novo AF in the immediate and longterm periods after endovascular PFO closure.
- 24 June 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (12S) , 6009
Open AccessAtrial fibrillation as a complication of endovascular patent foramen ovale closure: a clinical trial
One of the known potential complications associated with endovascular closure of the patent foramen ovale (PFO) is de novo atrial fibrillation (AF).Aim. To assess the risk factors and incidence of de novo AF in patients who underwent endovascular PFO closure.Material and methods. The data of 276 patients who underwent endovascular PFO closure for the period from 2020 to 2023 at the Chazov National Medical Research Center of Cardiology were analyzed. All patients underwent examinations in accordance with clinical guidelines. De novo AF in the postoperative period was assessed by Holter monitoring, while 1, 6 and 12 months after the intervention — by electrocardiographic recording. Based on univariate regression analysis, risk factors associated with de novo AF were identified.Results. De novo AF in the postoperative period was registered in 2 patients. One month after the intervention, AF episodes were diagnosed in 6 patients. After 6 months, AF detected earlier persisted in 3 patients,and there were 3 new cases. Twelve months after the intervention, AF was recorded in 2 patients. According to regression analysis, the following parameters were associated with de novo AF: age ≥52,0 years (hazard ratio (HR) 6,22; 95% confidence interval (CI): 1,51-25,56), body mass index ≥28,07 kg/m2 (HR 8,48; 95% CI: 1,72-41,73), CHARGE-AF score ≥0,56 (HR 4,59; 95% CI: 1,12-18,82), left atrial size ≥4,00 cm (HR 19,56; 95% CI: 2,10-181,88), LAVi ≥34 ml/m2 (HR 45,67; 95% CI: 5,46-381,83) according to echocardiography.Conclusion. Echocardiographic signs of left atrial and left ventricular dilation were significantly associated with a high risk of de novo AF in the immediate and longterm periods after endovascular PFO closure.